Progression of myelodysplasia during low-dose methotrexate therapy in rheumatoid arthritis.
Murphy
Philip T
PT
Fay
Michael J
MJ
Swords
Ronan T
RT
Quinn
John P
JP
O'Donnell
John R
JR
D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects*; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000139:chemically induced*
D018501:Antirheumatic Agents; D008727:Methotrexate